The FDA has restricted the importation of 11 products from Viatris’ Indian facility due to violations of federal requirements. With exceptions for four products facing shortages, Viatris is implementing a remediation plan and collaborating with third-party experts to address the issues. Communication with the FDA is ongoing during this process.
The FDA has restricted the importation of 11 products from Viatris’ Indian facility due to violations of federal requirements. With exceptions for four products facing shortages, Viatris is implementing a remediation plan and collaborating with third-party experts to address the issues. Communication with the FDA is ongoing during this process.